Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)
Conditions
Hemophilia B
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Republican Scientific and Practical Center for Radiation Medicine and Human Ecology, Homyel, Belarus
Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Belarus
State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital", Chelyabinsk, Russia
State budgetary healthcare institution Leningrad Regional Clinical Hospital, Gatchina, Russia
Kuzbass Clinical Hospital named after S.V. Belyaev, Kemerovo, Russia
Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency", Kirov, Russia
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders), Moscow, Russia
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia), Moscow, Russia
Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin", Moscow, Russia
LLC "Medis", Nizhny Novgorod, Russia
State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia
Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological Agency, Saint Petersburg, Russia
City Polyclinic №37, Saint Petersburg, Russia
Almazov National Medical Research Centre, Saint Petersburg, Russia
Federal State Budgetary Educational Institution of Higher Education "Samara State Medical University" of the Ministry of Healthcare of the Russian Federation, Samara, Russia
State Institution "Komi Republican Oncological Dispensary", Syktyvkar, Russia
Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation, Ufa, Russia
Study leads
Arina V Zinkina-Orikhan, MD
Study Director
Director of Clinical Development Department, BIOCAD